Cancer Immunology Project Awards
About this scheme
Cancer Immunology Project Awards postponed due to COVID-19
Due to the unprecedented financial impact of the COVID-19 pandemic, we’ve taken the difficult decision to postpone next Cancer Immunology Project Awards deadline until later in the year, to be considered at the spring 2021 round.
Since 2015, the Cancer Immunology Project Awards have supported innovative research in the field of cancer immunology. We look forward to reopening the scheme, ensuring that we continue to support world-leading cancer immunology research in the UK. Thank you to our research community for your continued support and understanding during these uncertain times.
Check back regularly to find out when the next round is opening – or sign up to Research Update, our monthly round-up of research opportunities, events and funding.
Applications are accepted from:
- Scientists, clinicians or health care workers from UK universities, medical schools, hospitals and some research institutes.
- The lead applicant (PI) must be an immunologist who should not have a demonstrated track record in cancer research.
- Collaborations with cancer researchers/clinicians are strongly encouraged to deliver the project but are not a mandatory requirement.
If you have a demonstrated track record in cancer, or are a group leader at a CRUK core-funded Institute, you are not eligible to apply for this award as the lead PI, but may act as a co-investigator or collaborator.
The aim of the scheme is to build capacity in cancer immunology; therefore, if you already have a demonstrated track record in cancer research, our other opportunities in discovery research may be more suitable for your research.
Your proposal should address key questions in the immunology of cancer. Applications can be in any area of immunological research, providing the cancer relevance is clearly articulated in the proposal, including any of the following key areas:
Cellular and molecular immunology: including but not limited to mechanisms of tolerance, the regulation of immune function, the development of memory, the interaction of immune cells with tissues and enhancing the immune system’s ability to detect and destroy cancer.
Inflammation, allergy, transplantation and autoimmunity: how the basic understanding of relevant mechanisms involved could drive forward our understanding of cancer as well as how sensing of endogenous changes in immune homeostasis, such as tissue damage, impacts on the sensing and development of cancers.
Immune response to infection: including but not limited to immunity and disease susceptibility/resistance and the development of adverse infections in response to immune therapy or biological drug intervention.
If you are looking for support for the discovery and development of new biotherapeutics or immunomodulatory agents, explore our opportunities in drug discovery and development.
How to apply to this scheme
- You must email us with a one-page summary of your proposal, a list of potential collaborators and your CV. We advise you do this at least one month before the deadline.
- If your proposal is eligible, we will invite you to make a formal application through our electronic Grants Management System (eGMS)
- Your application will be assessed by international peer review, before review by our Cancer Immunology Expert Review Panel.
- The final funding decision will be made by our Science Committee.
Applications for Cancer Immunology Project Awards are considered twice a year.
We will be announcing timelines for our Cancer Immunology Project Award grant application process in the near future.
Before you begin your application
The Science Committee will judge your proposal based on:
- Scientific excellence: all applications must have a strong scientific rationale, as well as appropriate experimental design and statistical analyses, to support the proposed research proposal.
- Cancer relevance: value of the proposed work in advancing the fundamental understanding of cancer or improving how cancer is diagnosed and/or treated.
- Track record: the lead applicant and/or team members should have an excellent track record and potential to produce outstanding results.
- Excellent team and collaborative environment: suitability and feasibility of the Lead Applicant(s) (and supporting roles) to carry out the proposed research with access to the resources and facilities required for the successful fulfilment of the Programme Award. The added value of the proposed collaboration and the individual contributions, as well as the steps taken to ensure an effective collaboration.
- Resources requested: the costs requested in an application should be for the direct costs of the research and be reasonably justified in line with the experimental plans, leveraging existing resources where appropriate.
Cancer Research UK contact details
When this funding scheme reopens, please contact the research funding manager for this scheme to discuss your proposal before starting your application.
Dr Iva Trenevska, Research Funding Manager
Tel: 020 3469 5257
More opportunities for discovery researchers
We support a broad portfolio of discovery research, including basic biology, genetics and immunology, biomarker discovery and preclinical studies, and engineering and physical sciences applied to cancer. We have a variety of grant funding and other opportunities to accelerate your research.
Andrew Mellor is using funding from our Immunology Project Award to explore the link between dying cells and inflammatory responses that promote cancer development.